Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTeladoc Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 6 | -$0.42 | -$0.20 | -$0.34 |
| Q2 2025 | 5 | -$0.30 | -$0.21 | -$0.26 |
| Q3 2025 | 6 | -$0.31 | -$0.21 | -$0.26 |
| Q4 2025 | 6 | -$0.24 | -$0.11 | -$0.18 |
| Q1 2026 | 5 | -$0.36 | -$0.15 | -$0.26 |
| Q2 2026 | 1 | -$0.22 | -$0.21 | -$0.21 |
| Q3 2026 | 1 | -$0.18 | -$0.17 | -$0.18 |
| Q4 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q1 2027 | 1 | -$0.25 | -$0.24 | -$0.25 |
| Q2 2027 | 1 | -$0.21 | -$0.20 | -$0.21 |
| Q3 2027 | 1 | -$0.20 | -$0.19 | -$0.19 |
| Q4 2027 | 1 | -$0.19 | -$0.18 | -$0.18 |
Teladoc Health, Inc. Earnings Date And Information
Teladoc Health, Inc. last posted its earnings results on Wednesday, October 29th, 2025. The company reported $-0.21 earnings per share for the quarter, topping analysts' consensus estimates of $-0.26 by $0.05. The company had revenue of 626.44 M for the quarter and had revenue of 2.57 B for the year. Teladoc Health, Inc. has generated $-6 earnings per share over the last year ($-5.87 diluted earnings per share) and currently has a price-to-earnings ratio of -5.94. Teladoc Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 29th, 2025 based on prior year's report dates.
Teladoc Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2025 | Q3 2025 | N/A | -$0.28 | N/A | $625.76 M | $626.44 M |
| 07/30/2025 | Q2 2025 | N/A | -$0.19 | N/A | $622.54 M | $631.90 M |
| 05/01/2025 | Q1 2025 | N/A | -$0.53 | N/A | N/A | $629.37 M |
| 02/27/2025 | Q4 2024 | N/A | -$0.28 | N/A | N/A | $640.49 M |
| 10/31/2024 | Q3 2024 | N/A | -$0.20 | N/A | $631.18 M | $640.51 M |
| 08/01/2024 | Q2 2024 | N/A | -$4.92 | N/A | $649.16 M | $642.44 M |
| 04/26/2024 | Q1 2024 | N/A | -$0.49 | N/A | N/A | $646.13 M |
| 02/23/2024 | Q4 2023 | N/A | -$0.17 | N/A | N/A | $660.53 M |
| 10/27/2023 | Q3 2023 | N/A | -$0.35 | N/A | $663.54 M | $660.24 M |
| 07/28/2023 | Q2 2023 | N/A | -$0.40 | N/A | $649.18 M | $652.41 M |
| 05/02/2023 | Q1 2023 | N/A | -$0.42 | N/A | $619.30 M | $629.24 M |
| 03/01/2023 | Q4 2022 | N/A | -$23.49 | N/A | $633.40 M | $637.71 M |
| 11/02/2022 | Q3 2022 | N/A | -$0.45 | N/A | $608.89 M | $611.40 M |
| 08/03/2022 | Q2 2022 | N/A | -$19.22 | N/A | $586.74 M | $592.38 M |
| 05/02/2022 | Q1 2022 | N/A | -$41.58 | N/A | $568.68 M | $565.35 M |
| 02/28/2022 | Q4 2021 | N/A | -$0.07 | N/A | $547.17 M | $554.24 M |
| 11/01/2021 | Q3 2021 | N/A | -$0.53 | N/A | $516.63 M | $521.66 M |
| 08/02/2021 | Q2 2021 | N/A | -$0.86 | N/A | $500.60 M | $503.14 M |
| 05/03/2021 | Q1 2021 | N/A | -$1.31 | N/A | $451.91 M | $453.68 M |
| 03/01/2021 | Q4 2020 | N/A | -$3.07 | N/A | $378.93 M | $383.32 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Teladoc Health, Inc. Earnings: FAQ's
Teladoc Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 29th, 2025 based offlast year's report dates.
In the previous quarter, Teladoc Health, Inc. (:TDOC) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.26 by $0.05.
The conference call for Teladoc Health, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Teladoc Health, Inc.'s latest earnings report can be read online.
Teladoc Health, Inc. (:TDOC) has a recorded annual revenue of $2.57 B.
Teladoc Health, Inc. (:TDOC) has a recorded net income of $-1,001,245,000.Teladoc Health, Inc. has generated $-5.87 earnings per share over the last four quarters.
Teladoc Health, Inc. (:TDOC) has a price-to-earnings ratio of -5.94 and price/earnings-to-growth ratio is 0.89.